{"id":19223,"date":"2025-03-06T14:40:52","date_gmt":"2025-03-06T17:40:52","guid":{"rendered":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/75276617ale1001-lma-r-r-com-npm1mut-ou-kmt2a-r\/"},"modified":"2025-03-06T14:40:52","modified_gmt":"2025-03-06T17:40:52","slug":"75276617ale1001-lma-r-r-com-npm1mut-ou-kmt2a-r","status":"publish","type":"ensaio_clinico","link":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/pesquisa\/ensaiosclinicos\/75276617ale1001-lma-r-r-com-npm1mut-ou-kmt2a-r\/","title":{"rendered":"75276617ALE1001 &#8211; LMA R\/R com NPM1mut ou KMT2A-r"},"content":{"rendered":"<div data-olk-copy-source=\"MessageBody\">Estudo de fase 1\/2 com Bleximenibe (inibidor de menin) em pacientes com LMA R\/R NPM1mut ou KMT2A-r.<\/div>\n<div><b>&nbsp;<\/b><\/div>\n<div><b>Popula\u00e7\u00e3o:&nbsp;<\/b>Idade&nbsp;<u>&gt;<\/u>&nbsp;18 anos. Diagn\u00f3stico inicial de LMA e doen\u00e7a R\/R (com ou sem transplante de c\u00e9lulas-tronco hematopoi\u00e9ticas). LMA apenas com muta\u00e7\u00f5es de KMT2A-r (rearranjo\/transloca\u00e7\u00e3o de genes) ou NPM1. ECOG 0 a 2.<\/div>\n<div>&nbsp;<\/div>\n<div><span data-olk-copy-source=\"MessageBody\"><strong>ClinicalTrials.gov:<\/strong> NCT04811560<\/span><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Estudo de fase 1\/2 com Bleximenibe (inibidor de menin) em pacientes com LMA R\/R NPM1mut ou KMT2A-r. &nbsp; Popula\u00e7\u00e3o:&nbsp;Idade&nbsp;&gt;&nbsp;18 anos. Diagn\u00f3stico inicial de LMA e doen\u00e7a R\/R (com ou sem transplante de c\u00e9lulas-tronco hematopoi\u00e9ticas). LMA apenas com muta\u00e7\u00f5es de KMT2A-r (rearranjo\/transloca\u00e7\u00e3o de genes) ou NPM1. ECOG 0 a 2. &nbsp; ClinicalTrials.gov: NCT04811560<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false},"class_list":["post-19223","ensaio_clinico","type-ensaio_clinico","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>75276617ALE1001 - LMA R\/R com NPM1mut ou KMT2A-r - IDOR - Instituto D&#039;Or de Pesquisa e Ensino<\/title>\n<link rel=\"canonical\" href=\"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/75276617ale1001-lma-r-r-com-npm1mut-ou-kmt2a-r\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"75276617ALE1001 - LMA R\/R com NPM1mut ou KMT2A-r - IDOR - Instituto D&#039;Or de Pesquisa e Ensino\" \/>\n<meta property=\"og:description\" content=\"Estudo de fase 1\/2 com Bleximenibe (inibidor de menin) em pacientes com LMA R\/R NPM1mut ou KMT2A-r. &nbsp; Popula\u00e7\u00e3o:&nbsp;Idade&nbsp;&gt;&nbsp;18 anos. Diagn\u00f3stico inicial de LMA e doen\u00e7a R\/R (com ou sem transplante de c\u00e9lulas-tronco hematopoi\u00e9ticas). LMA apenas com muta\u00e7\u00f5es de KMT2A-r (rearranjo\/transloca\u00e7\u00e3o de genes) ou NPM1. ECOG 0 a 2. &nbsp; ClinicalTrials.gov: NCT04811560\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/75276617ale1001-lma-r-r-com-npm1mut-ou-kmt2a-r\/\" \/>\n<meta property=\"og:site_name\" content=\"IDOR - Instituto D&#039;Or de Pesquisa e Ensino\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ptbr.idor.org\\\/pesquisa\\\/ensaiosclinicos\\\/75276617ale1001-lma-r-r-com-npm1mut-ou-kmt2a-r\\\/\",\"url\":\"https:\\\/\\\/ptbr.idor.org\\\/pesquisa\\\/ensaiosclinicos\\\/75276617ale1001-lma-r-r-com-npm1mut-ou-kmt2a-r\\\/\",\"name\":\"75276617ALE1001 - LMA R\\\/R com NPM1mut ou KMT2A-r - IDOR - Instituto D&#039;Or de Pesquisa e Ensino\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rededorsaoluiz.com.br\\\/instituto\\\/idor\\\/#website\"},\"datePublished\":\"2025-03-06T17:40:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ptbr.idor.org\\\/pesquisa\\\/ensaiosclinicos\\\/75276617ale1001-lma-r-r-com-npm1mut-ou-kmt2a-r\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ptbr.idor.org\\\/pesquisa\\\/ensaiosclinicos\\\/75276617ale1001-lma-r-r-com-npm1mut-ou-kmt2a-r\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ptbr.idor.org\\\/pesquisa\\\/ensaiosclinicos\\\/75276617ale1001-lma-r-r-com-npm1mut-ou-kmt2a-r\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/www.rededorsaoluiz.com.br\\\/instituto\\\/idor\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ensaios Cl\u00ednicos\",\"item\":\"https:\\\/\\\/ptbr.idor.org\\\/pesquisa\\\/ensaiosclinicos\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"75276617ALE1001 &#8211; LMA R\\\/R com NPM1mut ou KMT2A-r\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rededorsaoluiz.com.br\\\/instituto\\\/idor\\\/#website\",\"url\":\"https:\\\/\\\/www.rededorsaoluiz.com.br\\\/instituto\\\/idor\\\/\",\"name\":\"IDOR - Instituto D&#039;Or de Pesquisa e Ensino\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rededorsaoluiz.com.br\\\/instituto\\\/idor\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"75276617ALE1001 - LMA R\/R com NPM1mut ou KMT2A-r - IDOR - Instituto D&#039;Or de Pesquisa e Ensino","canonical":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/75276617ale1001-lma-r-r-com-npm1mut-ou-kmt2a-r\/","og_locale":"pt_BR","og_type":"article","og_title":"75276617ALE1001 - LMA R\/R com NPM1mut ou KMT2A-r - IDOR - Instituto D&#039;Or de Pesquisa e Ensino","og_description":"Estudo de fase 1\/2 com Bleximenibe (inibidor de menin) em pacientes com LMA R\/R NPM1mut ou KMT2A-r. &nbsp; Popula\u00e7\u00e3o:&nbsp;Idade&nbsp;&gt;&nbsp;18 anos. Diagn\u00f3stico inicial de LMA e doen\u00e7a R\/R (com ou sem transplante de c\u00e9lulas-tronco hematopoi\u00e9ticas). LMA apenas com muta\u00e7\u00f5es de KMT2A-r (rearranjo\/transloca\u00e7\u00e3o de genes) ou NPM1. ECOG 0 a 2. &nbsp; ClinicalTrials.gov: NCT04811560","og_url":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/75276617ale1001-lma-r-r-com-npm1mut-ou-kmt2a-r\/","og_site_name":"IDOR - Instituto D&#039;Or de Pesquisa e Ensino","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/75276617ale1001-lma-r-r-com-npm1mut-ou-kmt2a-r\/","url":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/75276617ale1001-lma-r-r-com-npm1mut-ou-kmt2a-r\/","name":"75276617ALE1001 - LMA R\/R com NPM1mut ou KMT2A-r - IDOR - Instituto D&#039;Or de Pesquisa e Ensino","isPartOf":{"@id":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/#website"},"datePublished":"2025-03-06T17:40:52+00:00","breadcrumb":{"@id":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/75276617ale1001-lma-r-r-com-npm1mut-ou-kmt2a-r\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/75276617ale1001-lma-r-r-com-npm1mut-ou-kmt2a-r\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/75276617ale1001-lma-r-r-com-npm1mut-ou-kmt2a-r\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/"},{"@type":"ListItem","position":2,"name":"Ensaios Cl\u00ednicos","item":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/"},{"@type":"ListItem","position":3,"name":"75276617ALE1001 &#8211; LMA R\/R com NPM1mut ou KMT2A-r"}]},{"@type":"WebSite","@id":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/#website","url":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/","name":"IDOR - Instituto D&#039;Or de Pesquisa e Ensino","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"}]}},"_links":{"self":[{"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/ensaio_clinico\/19223","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/ensaio_clinico"}],"about":[{"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/types\/ensaio_clinico"}],"wp:attachment":[{"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/media?parent=19223"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}